Liming Bao

Also affiliated with Forward Pharma (Germany), Weill Cornell Medicine

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Evolution of acquired resistance in a ROS1+ KRAS G12C+ NSCLC through the MAPK pathway”.

Evolution of acquired resistance in a ROS1+ KRAS G12C+ NSCLC through the MAPK pathway

npj Precision Oncology(2023)10.1038/s41698-023-00349-0

N/A

0.600DataRank · unranked

15 citations

Anh T. Le, Amanuail Gebregzabheir, Hala Nijmeh, Gregory B. Reis, Melanie Mandell +8 more

Evolution of MET and NRAS gene amplification as acquired resistance mechanisms in EGFR mutant NSCLC

npj Precision Oncology(2021)10.1038/s41698-021-00231-x

N/A

0.492DataRank · unranked

11 citations

Tejas Patil, Anh T. Le, Kurtis D. Davies, Peter Brzeskiewicz, Hala Nijmeh +5 more